AbbVie Inc. - Strategy, SWOT and Corporate Finance Report

November 2023 | 50 pages | ID: AC9C953D0DBEN
MarketLine

Abstracts

AbbVie Inc. %li%Strategy, SWOT and Corporate Finance Report

Summary

AbbVie Inc. %li%Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

AbbVie Inc. (AbbVie or ‘the company’) is a biopharmaceutical company that discovers, develops, manufactures and commercializes drugs for the treatment of chronic and complex diseases. The company develops pharmaceutical products that mainly consist of Humira (adalimumab) and products in therapeutic areas of oncology, metabolic/hormones, endocrinology, and virology. It also provides patient support programs and partners with academic institutions, biotechnology companies and other pharmaceutical companies. The company sells its products directly to distributors, wholesalers, health care facilities, specialty pharmacies, government agencies and independent retailers from the company-owned distribution centers and public warehouses. It has business presence in the US, the UK, Canada, Mexico, European Union, Japan, Brazil, and other countries. The company is headquartered in North Chicago, Illinois, the US.

Scope

• Detailed information on AbbVie Inc. required for business and competitor intelligence needs
• A study of the major internal and external factors affecting AbbVie Inc. in the form of a SWOT analysis
• An in-depth view of the business model of AbbVie Inc. including a breakdown and examination of key business segments
• Intelligence on AbbVie Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about AbbVie Inc., such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

• Gain understanding of AbbVie Inc. and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess AbbVie Inc. as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on AbbVie Inc.'s business structure, strategy and prospects.

Contents

Table of Contents
Company Snapshot
AbbVie Inc.: Company Overview
AbbVie Inc.: Overview and Key Facts
AbbVie Inc.: Overview
AbbVie Inc.: Key Facts
AbbVie Inc.: Key Employees
AbbVie Inc.: Key Employee Biographies
AbbVie Inc.: Major Products and Services
AbbVie Inc.: Management Statement
AbbVie Inc.: Locations and Subsidiaries
AbbVie Inc.: Key Competitors
AbbVie Inc.: Company Analysis
AbbVie Inc.: Business Description
AbbVie Inc.: SWOT Analysis
AbbVie Inc.: SWOT Overview
AbbVie Inc.: Strengths
AbbVie Inc.: Weaknesses
AbbVie Inc.: Opportunities
AbbVie Inc.: Threats
AbbVie Inc.: Corporate Financial Deals Activity
AbbVie Inc.: Financial Deals Overview
AbbVie Inc.: Targets and Partners
AbbVie Inc.: Top Deals 2019 - 2023YTD*
AbbVie Inc.: Advisors
AbbVie Inc.: Top Legal Advisors
AbbVie Inc.: Top Financial Advisors
AbbVie Inc.: Mergers and Acquisitions
AbbVie Inc.: Corporate Venturing
AbbVie Inc.: Capital Raising
AbbVie Inc.: Partnership
AbbVie Inc.: Divestments
AbbVie Inc.: Private Equity and Ownership
AbbVie Inc.: Recent Developments
AbbVie Inc.: News and Events Summary
AbbVie Inc.: Contracts
AbbVie Inc.: Market Developments
AbbVie Inc.: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

LIST OF TABLES

Table 1: AbbVie Inc.: Key Facts
Table 2: AbbVie Inc.: Key Employees
Table 3: AbbVie Inc.: Locations and Subsidiaries
Table 4: AbbVie Inc.: Key Competitors
Table 5: AbbVie Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: AbbVie Inc.: M&A Activity by Geography (TTM*)
Table 7: AbbVie Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 8: AbbVie Inc.: M&A Average Deal Size - Value (US$m)
Table 9: AbbVie Inc.: Targets and Partners
Table 10: AbbVie Inc.: Top Deals 2019 - 2023YTD*
Table 11: AbbVie Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: AbbVie Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: AbbVie Inc.: M&A Volume and Value Trend (2019 - YTD*2023)
Table 14: AbbVie Inc.: M&A Activity by Geography (2019 - YTD*2023)
Table 15: AbbVie Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Table 16: AbbVie Inc.: Corporate Venturing by Geography (2019 - YTD*2023)
Table 17: AbbVie Inc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Table 18: AbbVie Inc.: Capital Raising by Deal Type (2019 - YTD*2023)
Table 19: AbbVie Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 20: AbbVie Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 21: AbbVie Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Table 22: AbbVie Inc.: Divestments by Geography (2019 - YTD*2023)
Table 23: AbbVie Inc.: Private Equity and Ownership Volume and Value Trend (2019 - YTD*2023)
Table 24: AbbVie Inc.: Private Equity and Ownership Volume by Deal Type (2019 - YTD*2023)
Table 25: AbbVie Inc.: News and Events Summary
Table 26: AbbVie Inc.: Contracts
Table 27: AbbVie Inc.: Market Developments
Table 28: AbbVie Inc.: Research & Development

List Of Figures

LIST OF FIGURES

Figure 1: AbbVie Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: AbbVie Inc.: M&A Activity by Geography (TTM*)
Figure 3: AbbVie Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 4: AbbVie Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: AbbVie Inc.: M&A Volume and Value Trend (2019 - YTD*2023)
Figure 6: AbbVie Inc.: M&A Activity by Geography (2019 - YTD*2023)
Figure 7: AbbVie Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Figure 8: AbbVie Inc.: Corporate Venturing by Geography (2019 - YTD*2023)
Figure 9: AbbVie Inc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Figure 10: AbbVie Inc.: Capital Raising by Deal Type (2019 - YTD*2023)
Figure 11: AbbVie Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 12: AbbVie Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Figure 13: AbbVie Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Figure 14: AbbVie Inc.: Divestments by Geography (2019 - YTD*2023)
Figure 15: AbbVie Inc.: Private Equity and Ownership Volume and Value Trend (2019 - YTD*2023)
Figure 16: AbbVie Inc.: Private Equity and Ownership Volume by Deal Type (2019 - YTD*2023)